Home › Funds › Portolan Capital Management, LLC › CSTL
Portolan Capital Management, LLC position in CSTL
CASTLE BIOSCIENCES INC · Health Care
Portolan Capital Management, LLC reported holding 1,372,870 shares of CSTL (CASTLE BIOSCIENCES INC) in its Q3 2026 13F filing — a position valued at US$48.8M, representing 2.03% of its reported portfolio and ranking #8 among its reported holdings. Portolan Capital Management, LLC has disclosed CSTL holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Portolan Capital Management, LLC's CSTL position evolved
Portolan Capital Management, LLC first disclosed a stake in CSTL in Q3 2023 at 253,028 shares (US$4.3M). The position peaked in Q4 2025 at 1,729,463 shares, worth US$67.3M. Across 13 filings, Portolan Capital Management, LLC increased the stake 9 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,372,870 shares valued at US$48.8M — an increase of 1,044,052 shares quarter over quarter.. Notable position changes include a 188% increase in Q4 2023 (shares rose 3% over the following quarter), a 76% trim in Q2 2026 (shares rose 49% over the following quarter), a 318% increase in Q3 2026 (shares fell 8% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 253.03K | $4.27M | New |
| Q4 2023 | 728.65K | $15.72M | Add |
| Q1 2024 | 1.04M | $23.11M | Add |
| Q2 2024 | 1.21M | $26.36M | Add |
| Q3 2024 | 1.26M | $35.81M | Add |
| Q4 2024 | 776.58K | $20.70M | Reduce |
| Q1 2025 | 1.27M | $25.33M | Add |
| Q2 2025 | 1.49M | $30.42M | Add |
| Q3 2025 | 1.52M | $34.50M | Add |
| Q4 2025 | 1.73M | $67.28M | Add |
| Q1 2026 | 1.35M | $33.15M | Reduce |
| Q2 2026 | 328.82K | $7.84M | Reduce |
| Q3 2026 | 1.37M | $48.78M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CSTL and 13F data
CSTL (CASTLE BIOSCIENCES INC) is a Health Care company. 36 other funds we track also report a position in CSTL — the largest reported positions include RTW INVESTMENTS, LP (US$98.7M), SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC (US$22.6M), BRAIDWELL LP (US$17.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CSTL
- RTW INVESTMENTS, LP 2.78M sh · $98.71M · Q3 2026
- SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 635.00K sh · $22.56M · Q3 2026
- BRAIDWELL LP 502.51K sh · $17.85M · Q3 2026
- Parkman Healthcare Partners LLC 367.91K sh · $13.07M · Q3 2026
More on Portolan Capital Management, LLC
FAQ
How long has Portolan Capital Management, LLC held CSTL?
Portolan Capital Management, LLC has disclosed CSTL holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Portolan Capital Management, LLC's current position in CSTL?
As of Q3 2026, Portolan Capital Management, LLC holds 1.37M shares of CSTL (CASTLE BIOSCIENCES INC), valued at $48.78M, representing 2.03% of its reported portfolio and ranking #8.
Has Portolan Capital Management, LLC been buying or selling CSTL?
In the latest 13F filing (Q3 2026), Portolan Capital Management, LLC increased its position in CSTL. The position peaked in Q4 2025 at 1.73M shares.
Which other funds hold CSTL?
Other major institutional holders of CSTL include RTW INVESTMENTS, LP, SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC, BRAIDWELL LP, among 36 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.